Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.61 |
| ▸ | MAOA | P21397 | 1/20 | 0.61 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.46 |
| ▸ | KDM1A | O60341 | 3/20 | 0.46 |
| ▸ | RCOR1 | Q9UKL0 | 3/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 4/20 | 0.41 |
| ▸ | AGXT | P21549 | 2/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1823777 | 0.91 | MAOA (0.52) | MAOBMAOALOXL2KDM1ARCOR1 | |
| Hydrochloric Acid SCHEMBL3969767 | 0.90 | MAOB (0.50) | MAOBMAOALOXL2KDM1ARCOR1 | |
| SCHEMBL1823450 | 0.79 | MAOB (0.64) | MAOBMAOALOXL2KDM1A | |
| SCHEMBL2470972 | 0.78 | TAAR1 (0.50) | MAOBMAOALOXL2KDM1ARCOR1 | |
| SCHEMBL23601588 | 0.77 | MAOA (0.61) | MAOBMAOATAAR1IDO1AGXT | |
| SCHEMBL1823510 | 0.77 | MAOA (0.50) | MAOBMAOAKDM1ARCOR1IDO1 | |
| SCHEMBL1823270 | 0.77 | MAOA (0.61) | MAOBMAOAKDM1ARCOR1TAAR1 | |
| SCHEMBL16041470 | 0.77 | MAOA (0.61) | MAOBMAOAKDM1ARCOR1TAAR1 | |
| SCHEMBL5644096 | 0.77 | MAOA (0.61) | MAOBMAOAKDM1AIDO1 | |
| SCHEMBL1821734 | 0.77 | MAOA (0.61) | MAOBMAOATAAR1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3606910-A1 | TRIAZOLE COMPOUND AND USE THEREOF IN AGRICULTURE | Dongguan Hec Pesticides R&D Co., Ltd. (CN) | 2020-02-12 | — | — | EP | disclosed |
| WO-2018184579-A1 | TRIAZOLE COMPOUND AND USE THEREOF IN AGRICULTURE | DONGGUAN HEC TECH R&D CO., LTD. (CN) | 2018-10-11 | — | — | WO | disclosed |
| US-20120053165-A1 | Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators | PFIZER INC. (US) | 2012-03-01 | — | — | US | disclosed |
| US-20120053165-A1 | Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators | PFIZER INC. (US) | 2012-03-01 | — | — | US | disclosed |
| WO-2010100606-A1 | NOVEL PHENYL IMIDAZOLES AND PHENYL TRIAZOLES AS GAMMA-SECRETASE MODULATORS | PFIZER INC. (US) | 2010-09-10 | — | — | WO | disclosed |
| US-7217723-B2 | Substituted benzothiophenes, e.g., 7Z)-7-hydroxyimino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-sulfonic acid [2-(4-fluorophenyl)-2-hydroxyethyl]-methyl-amide; treating allergies such as atopic dermatitis, allergic coryza, bronchial asthma, hypersensitive pneumoniac and pulmonary aspergillosis. | EISAI CO., LTD. (JP) | 2007-05-15 | — | — | US | disclosed |
| US-20050227959-A1 | Heterocyclic compound having oxime group | EISAI CO., LTD. (JP) | 2005-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053165-A1 | Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators | BACE1, BACE2, PSEN1 | MAOB 1367/4885MAOA 1573/4885LOXL2 4378/4885 |
| US-20050227959-A1 | Heterocyclic compound having oxime group | STAT6, HRH4, HRH2 | MAOB 913/4885MAOA 1201/4885LOXL2 1145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.